Top Suppliers:I want be here

  • DC Chemicals Limited
  • China
  • Product Name: PE859
  • Price: $650.0/100mg $1200.0/250mg $2500.0/1g
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

1402727-29-0

1402727-29-0 structure
1402727-29-0 structure
  • Name: PE859
  • Chemical Name: PE859
  • CAS Number: 1402727-29-0
  • Molecular Formula: C28H24N4O2
  • Molecular Weight: 448.516
  • Catalog: Signaling Pathways Cell Cycle/DNA Damage Microtubule/Tubulin
  • Create Date: 2018-01-11 16:52:23
  • Modify Date: 2024-02-01 10:34:15
  • PE859 is a potent inhibitor of both tau and Aβ aggregation with IC50 values of 0.66 and 1.2 μM, respectively.

Name PE859
Synonyms 1H-Indole, 6-[(E)-2-[3-[(E)-2-[2-methoxy-4-(2-pyridinylmethoxy)phenyl]ethenyl]-1H-pyrazol-5-yl]ethenyl]-
6-[(E)-2-(3-{(E)-2-[2-Methoxy-4-(2-pyridinylmethoxy)phenyl]vinyl}-1H-pyrazol-5-yl)vinyl]-1H-indole
Description PE859 is a potent inhibitor of both tau and Aβ aggregation with IC50 values of 0.66 and 1.2 μM, respectively.
Related Catalog
Target

IC50: 0.66 μM (tau), 1.2 μM (Aβ)[1]

In Vitro PE859 inhibits the heparin-induced aggregation of both 3RMBD and full length tau in a concentration-dependent manner. In each assay, the IC50 values calculated at the last measurement periods are 0.81 μM, and 2.23 μM, respectively. PE859 inhibits tau aggregation through formation of beta-sheet structure[2].
In Vivo PE859 could cross the blood-brain barrier and that PE859 could be distributed into the tissues of the central nervous system. The maximum concentration of PE859 is 2.005 μg/mL in the blood at 3 h and 1.428 μg/g in the brain at 6 h. PE859 delays onset and progression of the motor dysfunction in JNPL3 mice. PE859 delays progression of the motor dysfunction through the inhibition of accumulation of sarkosyl-insoluble tau. [2]
Kinase Assay Tau aggregation is monitored using thioflavin T. The test compound (PE859), 10 μM 3RMBD and 10 μM heparin are dissolved in 50 mM Tris-HCl (pH7.6), and incubated at 37°C up to 144 hours. At each point of incubation time, 135 μL of the solutions are removed and mixed with 15 μL of 100 μM ThT solution (final concentration: 10 μM) and the fluorescence intensity with excitation at 440 nm and emission at 486 nm is measured[2].
Animal Admin Mice: PE859 is dissolved in 80% PEG400 and 20% water solution at 5 mg/mL, and orally-administered at a dose of 40 mg/kg/day for 6 months (from 9 to 15 months of age). The body weights of the mice are measured once a week during PE859 treatment[2].
References

[1]. Okuda M, et al. Design and synthesis of curcumin derivatives as tau and amyloid β dual aggregation inhibitors. Bioorg Med Chem Lett. 2016 Oct 15;26(20):5024-5028.

[2]. Okuda M, et al. PE859, a novel tau aggregation inhibitor, reduces aggregated tau and prevents onset and progression of neural dysfunction in vivo. PLoS One. 2015 Feb 6;10(2):e0117511.

Density 1.3±0.1 g/cm3
Boiling Point 747.7±60.0 °C at 760 mmHg
Molecular Formula C28H24N4O2
Molecular Weight 448.516
Flash Point 249.8±23.1 °C
Exact Mass 448.189911
LogP 5.47
Vapour Pressure 0.0±2.4 mmHg at 25°C
Index of Refraction 1.768
Storage condition 2-8℃